Australian fast bowler Megan Schutt has received a two-match suspension for breaching regulations governing prescription medication. Cricket Australia confirmed the decision on Thursday, October 22, 2026.
The governing body said the breach involved a failure to follow its Sports Science and Sports Medicine guidelines. However, it clarified that the incident occurred outside competition and was not related to performance enhancement.
Schutt to Miss Two Matches
The suspension means Schutt will miss Australia’s third and final T20 international against New Zealand. She will also be unavailable for the Adelaide Strikers’ opening match of the Women’s Big Bash League against the Melbourne Stars on October 31.
The 33-year-old accepted the penalty and apologised for failing to meet the standards expected of her. She also acknowledged her responsibility to follow the medication guidelines provided to players.
Cricket Australia Clarifies the Breach
Cricket Australia stressed that the case involved a single incident outside competition. It also clarified that the matter did not involve performance-enhancing substances.
The governing body said it would continue supporting Schutt while reinforcing the responsibilities expected of professional players. Its guidelines require athletes to follow established procedures when using prescription medication.
Schutt’s Recent Performances
Schutt recently delivered a strong performance in Australia’s one-day international series against Bangladesh, taking 10 wickets. Her suspension comes as Australia continues its international cricket schedule.
The case highlights the importance of medication compliance in professional sport, even when an incident occurs outside competition. Athletes must follow the relevant rules to ensure their treatment meets governing-body requirements.
or the latest updates, visit and follow The Truth International website (www.thetruthinternational.com) and subscribe to the YouTube Channel.
